MediPharm Labs (TSE:LABS) has released an update.
MediPharm Labs reported a notable increase in its third-quarter net revenue, driven by a strong 37% growth in international medical cannabis sales. The company has successfully eliminated its convertible debt, showcasing a solid financial position with production efficiency and cost reductions contributing to a 29% improvement in gross profit.
For further insights into TSE:LABS stock, check out TipRanks’ Stock Analysis page.
